Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Post by JDavenporton Dec 15, 2022 4:32pm
198 Views
Post# 35174320

Some of you think...

Some of you think...Some of you think this is a game. Others see it as justification for expressing unbridled anger. or for taking a run at me and others.

You stand to lose everything here and there may be ways of preventing that. 

All of the things that I have noticed over the last couple of years, and especially since the "accretive" value promised by Dr. Deborah Rathjen through her machinations with Ladenburg Thalmann, have been found in this "merger."

The agreement is purposefully complex. It's hard to figure out and it includes many more vulnerabilities than Bioasis shareholders would have without the deal.

Some of you han't a hope in hell of figuring it out. No offense, just the way it is.

You have every right to express yourseves as you see fit. But this deal is everything that some of us worried about four years ago when Dr.Deborah Rathjen was taking over the company as CEO, and before that as Executive Chair, a pompous post if ever there was one designed to satisfy the ego of an otherwise failed CEO.

Instead of lining up to take shots at others, perhaps you ought to give some thought to saving your investment in Bioasis, because right now, it looks like you just want to fiddle while Rome burns.

I can tell you that I'm worth more in the tent than outside of it.

Just stop. This is serious.

The Webinar - Getting Good Information

If I am wrong, it will do no harm to you.

If I am right, you will be harmed by this deal unless you do something.

jd


<< Previous
Bullboard Posts
Next >>